Stay updated with breaking news from Tryp shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
San Diego, California (Newsfile Corp. - August 18, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds ....
Tryp has also entered into an agreement with Gad Consulting Services to collaborate on the preclinical studies San Diego, California (Newsfile Corp. - August 10, 2021) - Tryp Therapeutics (CSE: TRYP) ....
SonicShares™ announced the recent launch of the SonicShares™ Airlines, Hotels, Cruise Lines ETF (NYSE Arca: TRYP), which tracks the Solactive Airlines, Hotels, Cruise Lines Index. ....
San Diego, California (Newsfile Corp. - June 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet ....
Tryp Therapeutics Inc.: Tryp Therapeutics Partners with Alcami for Proprietary Formulations The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp s Psilocybin-For-Neuropsychiatric Disorder (PFN) program San Diego, California (Newsfile Corp. - May 25, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ( Tryp ), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today an agreement with Alcami Corporation ( Alcami ), a global pharmaceutical contract development and manufacturing organization (CDMO), to support the proprietary formulation of products for Tryp s Psilocybin-for-Neuropsychiatric Disorders (PFNTM) program. Tryp s collaboration with Alcami will initially focus on developing oral formulations for Tryp s proprietary psilocybin Active Pharmaceutical Ingredient ( API ) being manufactured by Alba ....